Nia Therapeutics

Tap into our visual timeline, highlighting major milestones in scientific and technological development.

2014

The DARPA Restoring Active Memory project begins at the University of Pennsylvania, with the intention to develop a personalized brain stimulation therapy.

2019

Nia acquires ASIC technology for brain sensing and stimulation.

2026

First clinical trial expected to start enrolling.

2000-2014

Foundational scientific work describing the brain signals underlying human memory function.

2018

First demonstration of personalized neurostimulation to improve human memory. Nia Therapeutics is founded.

2023

First demonstration of improved memory performance in patients with a history of TBI.

Our Team

We are assembling an incredible team of scientists, engineers, and clinicians to bring this vital therapy to market and to help the patients who need it most.

Dr. Michael Kahana

Founder & CEO

Dr. Mike Kahana is the founder of the Computational Memory Lab and Edmund J. and Louise W. Kahn Term Professor of Psychology at the University of Pennsylvania. He is the co-founder of nia Therapeutics and co-inventor of Nia’s core technology for treating memory loss.

Dr. Daniel Rizzuto

Founder, President and CTO

Dr. Dan Rizzuto is the founder, President, and Chief Technology Officer at Nia Therapeutics. Dan developed Nia’s core technology for treating memory disorders with Dr. Michael Kahana at the University of Pennsylvania, where they demonstrated, for the first time, that personalized neurostimulation could...

Chuck Vadala

Senior Director of Systems Engineering

Daniel Utin

Chief Software Architect

Dr. Zhe Hu

Principal Electrical Engineer

Chris Ho

Principal Software Developer

Josh Kahn

Senior Embedded Software Engineer

Andrew Smiles

Senior Biomedical Engineer

Advisors

Leading medical, scientific, and engineering advisors help to develop our plans.